The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | BTOG 2023 highlights
Gerard M. Walls, MB, MRCP, MSc, FRCR, Queen’s University, Belfast, UK, speaks on his highlights from the British Thoracic Oncology Group (BTOG) Annual Conference 2023. He particularly notes the SYSTEMS-2 clinical trial data, the presentations on immunotherapy and using therapeutics in combination, and a management meeting for the on-going CONCORDE clinical trial (NCT04550104) as highlights. This interview took place at the BTOG Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
